Raymond James & Associates Amphastar Pharmaceuticals, Inc. Transaction History

Raymond James & Associates

$146 Billion
Q1 2024

A detailed history of Raymond James & Associates transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 98,145 shares of AMPH stock, worth $3.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,145

Previous 92,659 5.92%

Holding current value

$3.93 Million

Previous $5.73 Million 24.8%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$42.85 - $63.45 $235,075 - $348,086	5,486 Added 5.92%	98,145 $4.31 Million
Q4 2023 Jan 16, 2024	BUY	$44.49 - $62.93 $1.78 Million - $2.51 Million	39,916 Added 75.68%	92,659 $5.73 Million
Q3 2023 Oct 24, 2023	SELL	$45.51 - $65.0 $110,361 - $157,625	-2,425 Reduced 4.4%	52,743 $2.43 Million
Q2 2023 Jul 25, 2023	BUY	$35.77 - $58.38 $1.13 Million - $1.85 Million	31,607 Added 134.15%	55,168 $3.17 Million
Q1 2023 Apr 14, 2023	BUY	$27.99 - $37.92 $13,519 - $18,315	483 Added 2.09%	23,561 $883,000

Q4 2022 Feb 08, 2023	SELL	$27.93 - $31.27 $79,153 - $88,619	-2,834 Reduced 10.94%	23,078 $646,000
Q3 2022 Oct 25, 2022	BUY	$27.56 - $37.75 $210,255 - $287,994	7,629 Added 41.73%	25,912 $728,000
Q2 2022 Aug 12, 2022	BUY	$29.79 - $42.29 $47,395 - $67,283	1,591 Added 9.53%	18,283 $636,000
Q1 2022 May 11, 2022	BUY	$22.96 - $36.45 $383,248 - $608,423	16,692 New	16,692 $599,000
Q1 2021 May 14, 2021	SELL	$17.21 - $20.65 $235,191 - $282,202	-13,666 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$17.76 - $21.24 $26,302 - $31,456	-1,481 Reduced 9.78%	13,666 $275,000
Q3 2020 Nov 04, 2020	BUY	$17.99 - $22.22 $26,445 - $32,663	1,470 Added 10.75%	15,147 $284,000
Q2 2020 Jul 28, 2020	BUY	$14.25 - $22.46 $194,897 - $307,185	13,677 New	13,677 $307,000
Q3 2019 Nov 07, 2019	SELL	$19.12 - $22.62 $730,976 - $864,785	-38,231 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$18.92 - $22.96 $36,780 - $44,634	1,944 Added 5.36%	38,231 $807,000
Q1 2019 May 06, 2019	SELL	$19.46 - $25.28 $55,908 - $72,629	-2,873 Reduced 7.34%	36,287 $741,000
Q4 2018 Feb 11, 2019	SELL	$17.72 - $22.51 $8,009 - $10,174	-452 Reduced 1.14%	39,160 $779,000
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $70,224 - $88,430	4,563 Added 13.02%	39,612 $762,000
Q2 2018 Aug 14, 2018	BUY	$14.63 - $19.6 $18,975 - $25,421	1,297 Added 3.84%	35,049 $535,000
Q1 2018 May 14, 2018	BUY	$17.23 - $20.35 $137,650 - $162,576	7,989 Added 31.01%	33,752 $633,000
Q4 2017 Feb 14, 2018	SELL	$17.76 - $19.75 $8,080 - $8,986	-455 Reduced 1.74%	25,763 $496,000
Q3 2017 Nov 13, 2017	BUY	$14.73 - $17.99 $386,191 - $471,661	26,218	26,218 $469,000

Others Institutions Holding AMPH

# of Institutions

276

Shares Held

33.4M

Call Options Held

56.6K

Put Options Held

57.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.96B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Amphastar Pharmaceuticals, Inc. Transaction History